SCHEMBL6173033

SCHEMBL6173033

CCCC1=CCc2ccc(NC(=O)NN(C)C)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.41
MTNR1A P48039 2/20 0.41
MTNR1B P49286 2/20 0.41
RAB9A P51151 5/20 0.37
HTR6 P50406 1/20 0.37
POLB P06746 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPC1 O15118 4/20 0.36
TERT O14746 1/20 0.35
HTR7 P34969 1/20 0.35
MCHR1 Q99705 1/20 0.35
MAPT P10636 2/20 0.35
MAPK1 P28482 1/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
HRH3 Q9Y5N1 1/20 0.33
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166177 0.72 RARA (0.42) RAB9APOLBNPC1MAPTMAPK1
SCHEMBL6168298 0.72 PTPN7 (0.40) RAB9APOLBTDP1NPC1MAPT
SCHEMBL8433785 0.70 HTR7 (0.45) NQO2MTNR1AMTNR1BHTR6HTR7
SCHEMBL8246440 0.67 HTR7 (0.45) NQO2MTNR1AMTNR1BHTR7
SCHEMBL918970 0.63 SAE1 (0.57) RAB9APOLBNPC1MAPTHRH3
SCHEMBL8868349 0.63 HRH3 (0.58) RAB9ANPC1MAPTMAPK1HRH3
SCHEMBL13102959 0.62 RAB9A (0.59) RAB9APOLBTDP1NPC1MAPT
SCHEMBL2973646 0.62 HTR7 (0.43) NQO2MTNR1AMTNR1BRAB9ATDP1
SCHEMBL29120621 0.62 ALDH1A1 (0.56) MTNR1AMTNR1BRAB9APOLBNPC1
SCHEMBL31728956 0.61 MAOA (0.58) RAB9APOLBTDP1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed